Fingerprint
Dive into the research topics of 'Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: Findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically